Tenet Healthcare (NYSE: THC) holder plans new sale after $13.9M trade

Rhea-AI Filing Summary

Tenet Healthcare Corp (THC) is named as the issuer in a notice that Saumya S. Sutaria intends to sell common stock under Rule 144. The filing indicates a planned sale of 50,000 common shares of Tenet Healthcare through Fidelity Brokerage Services LLC on the NYSE around 08/25/2026. The shares to be sold are linked to restricted stock vesting awards received from the issuer as compensation, including 47,162 shares vesting on 02/23/2025 and 2,838 shares vesting on 03/01/2024. The notice also reports a prior sale during the past three months of 50,000 common shares on 08/24/2026.

Key Figures

Planned shares to be sold: 50,000 shares Shares sold in past 3 months: 50,000 shares Aggregate value of past sale: 13935240.26 +2 more

5 metrics

Planned shares to be sold 50,000 shares Common stock sale through Fidelity Brokerage Services LLC, approximate date 08/25/2026

Shares sold in past 3 months 50,000 shares Common stock sale on 08/24/2026 reported under Securities Sold During The Past 3 Months

Aggregate value of past sale 13935240.26 Aggregate transaction amount for 50,000 shares sold on 08/24/2026

Restricted stock vesting award 47,162 shares Restricted stock vesting on 02/23/2025 from issuer as compensation

Restricted stock vesting award 2,838 shares Restricted stock vesting on 03/01/2024 from issuer as compensation

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 02/23/2025 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Saumya S. Sutaria"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing disclose for Tenet Healthcare Corp (THC)?

It discloses that Saumya S. Sutaria has filed a notice of intent to sell 50,000 shares of Tenet Healthcare common stock under Rule 144 through Fidelity Brokerage Services LLC, with an approximate sale date of 08/25/2026 on the NYSE.

How many Tenet Healthcare (THC) shares are planned to be sold under this Form 144?

The notice states that 50,000 common shares of Tenet Healthcare are planned to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 08/25/2026.

What Tenet Healthcare (THC) share sales in the past three months are reported?

The filing reports that 50,000 common shares of Tenet Healthcare were sold on 08/24/2026, with an aggregate transaction value of 13935240.26 stated in the disclosure.

What is the source of the Tenet Healthcare (THC) shares being sold under Rule 144?

The shares are tied to restricted stock vesting awards from Tenet Healthcare as compensation, including 47,162 shares vesting on 02/23/2025 and 2,838 shares vesting on 03/01/2024.

Who is the person selling Tenet Healthcare (THC) shares in this Form 144?

The notice is filed for the account of Saumya S. Sutaria. The signature is provided by Fidelity Brokerage Services LLC, acting as attorney-in-fact for Saumya S. Sutaria through a duly authorized representative.

Which broker is handling the planned Tenet Healthcare (THC) share sale?

The planned sale of 50,000 Tenet Healthcare common shares is to be executed through Fidelity Brokerage Services LLC, with the shares listed for trading on the NYSE as stated in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 02:10 PM Accepted by SEC EDGAR 08/25/2026 - 02:09 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001760857
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TENET HEALTHCARE CORP
SEC File Number	001-07293
Address of Issuer	14201 DALLAS PARKWAY DALLAS TEXAS 75254
Phone	469-893-2200
Name of Person for Whose Account the Securities are To Be Sold	Sutaria Saumya
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	50000	13701028.21	80519000	08/25/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2025	Restricted Stock Vesting	Issuer			47162	02/23/2025	Compensation
Common	03/01/2024	Restricted Stock Vesting	Issuer			2838	03/01/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Saumya S. Sutaria 14201 Dallas Parkway Dallas TX 75254	Common	08/24/2026	50000	13935240.26

144: Remarks and Signature

Remarks
Date of Notice	08/25/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Saumya S. Sutaria
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)